Assess Satisfaction of Patients and Physicians With Results of Yaz Plus Treatment for 13 Cycles
NCT02159261 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1500
Last updated 2017-08-09
Summary
Local prospective multicenter non-comparative non-interventional observational study. It's planed to assess satisfaction of patients and physicians with results of Yaz Plus treatment for 13 cycles in real practice.
Conditions
- Contraception
Interventions
- DRUG
-
BAY98-7071_EE20/DRSP/L-5-MTHF
Patients treated by Physicians under approved local prescriptions
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Bayer Study Director · Bayer
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2014-07-15
- Primary Completion
- 2016-08-14
- Completion
- 2016-08-14
Countries
- Russia
More Related Trials
-
Study to Investigate Compliance With the Oral Contraceptive SH T00186D in a Flexible Extended Regimen Supported by a Dispenser With a Reminder Function
NCT01257984 ·Status: COMPLETED ·Phase: PHASE3
-
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
NCT05934942 ·Status: TERMINATED ·Phase: PHASE1
-
YAZ Post Authorization Safety Study (PASS)/Post Authorization Efficacy Study (PAES) in China
NCT02710708 ·Status: COMPLETED ·Phase: PHASE4
-
Yasmin Post Marketing Surveillance
NCT00923572 ·Status: COMPLETED
-
Study to Evaluate the Effect of Six Cycles of Treatment With a Combined Oral Contraceptive (EE 0.30 mg/DRSP 3 mg) on Quality of Life.
NCT00367276 ·Status: COMPLETED ·Phase: PHASE3
-
To Investigate Efficacy of YAZ in the Treatment of Dysmenorrhea
NCT02617537 ·Status: WITHDRAWN ·Phase: PHASE3
-
Effects of Counseling on the Continuation Rates and Compliance for Newly Prescribed Oral Contraceptives (Yasmin® or Any Other Oral Contraceptives (OC)
NCT00905684 ·Status: COMPLETED
-
Non-interventional, Real Life Study on Satisfaction With LNG-IUS in Spanish Young Women (18-30 Years Old) With Different Parity Status and Menstrual Bleeding Pattern
NCT03493295 ·Status: COMPLETED
-
SH T00186 in the Treatment of Primary Dysmenorrhea
NCT00569244 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate Inhibition of Ovulation of Two Oral Estrogen/Progestogen Regimens in Healthy, Young Females Over a Period of 3 Treatment Cycles
NCT00631124 ·Status: COMPLETED ·Phase: PHASE2
-
Data on Oral Contraceptives Compliance in Non Stop Regimen
NCT01185678 ·Status: COMPLETED
-
KYleena Satisfaction Study / Observational Study on User Satisfaction With the Levonorgestrel Intrauterine Delivery System Kyleena (LNG-IUS 12) in New Contraceptive Users and After Switching From Another Contraceptive Method
NCT03182140 ·Status: COMPLETED
-
YAZ Premenstrual Dysphoric Disorder (PMDD) in China
NCT00824187 ·Status: COMPLETED ·Phase: PHASE3
-
Regulatory Post Marketing Surveillance Study on YAZ
NCT00998257 ·Status: COMPLETED
-
Evaluate Safety and Efficacy of an OC Preparation vs Placebo for 6 Treatment Cycles in Women With Moderate Acne.
NCT00651469 ·Status: COMPLETED ·Phase: PHASE3
-
Drospirenone/Ethinyl Estradiol (3 mg/0.02 mg) Tablets Under Fasting Conditions.
NCT01182194 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Drospirenone-containing or -Not Containing Combined Oral Contraceptives on General and Sexual Well-being
NCT00988910 ·Status: COMPLETED
-
Study to Evaluate the Pharmacokinetics of an Oral Contraceptive Containing Levonorgestrel and Ethinyl Estradiol When Co-administered With GSK1265744 in Healthy Adult Female Subjects
NCT02159131 ·Status: COMPLETED ·Phase: PHASE1
-
Drospirenone (3 mg) + Ethinyl Estradiol (0.02 mg) Tablets Relative to Yaz®
NCT06233071 ·Status: RECRUITING ·Phase: PHASE1
-
Safety and Efficacy Of Drospirenone and Ethinyl Estradiol vs Placebo in the Treatment of Truncal Acne
NCT00722761 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Investigate Efficacy and Safety of a New Oral Contraceptive
NCT00185289 ·Status: COMPLETED ·Phase: PHASE3
-
Open-Label Study to Evaluate the Safety and Efficacy of a Low-Dose 28-Day Oral Contraceptive
NCT00362479 ·Status: COMPLETED ·Phase: PHASE3
-
Drospirenone (3 mg) + Ethinyl Estradiol (0.03 mg) Tablets Relative to Yasmin®
NCT06233058 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
A Study to Evaluate the Pharmacokinetics of an Oral Contraceptive When Co-administered With GSK2248761 in Healthy Adult Female Subjects.
NCT01195974 ·Status: TERMINATED ·Phase: PHASE1
-
GA YAZ ACNE in China Phase III
NCT00818519 ·Status: COMPLETED ·Phase: PHASE3